Rigel Pharmaceuticals Eulerpool Nieuws

Rigel Pharmaceuticals Eulerpool News

Rigel Pharmaceuticals Aandeel Nieuws

Rigel Pharmaceuticals wordt door vele journalisten en beleggers wereldwijd gevolgd. De meest actuele Rigel Pharmaceuticals nieuwsberichten verzamelen we hier.

• 27 september ·

  Yahoo
  High Growth Tech Stocks in the United States to Watch
• 25 september ·

  Yahoo
  Rigel (RIGL) Surges 19.7%: Is This an Indication of Further Gains?
• 12 september ·

  Yahoo
  Rigel to Present at the 2024 Cantor Global Healthcare Conference
• 6 september ·

  Yahoo
  Rigel enrols first participant in Phase Ib/II AML treatment regimen trial
• 5 september ·

  Yahoo
  Rigel Announces First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA® (olutasidenib) in mIDH1 AML
• 5 september ·

  PR Newswire
  Rigel Announces First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA? (olutasidenib) in mIDH1 AML
• 5 september ·

  Thefly.com
  Rigel Pharmaceuticals: First patient enrolled in Phase 1b/2 REZLIDHIA trial
• 3 september ·

  Yahoo
  Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republic of Korea and Taiwan
• 3 september ·

  TipRanks
  Buy Rating Affirmed for Rigel with Positive Outlook on Asian Market Expansion and Solid NPV Valuation
• 3 september ·

  PR Newswire
  Rigel Expands Relationship with Kissei to include REZLIDHIA? (olutasidenib) in Japan, the Republic of Korea and Taiwan